| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| No holdings reported for quarter Q2 2021 | ||||||||
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| SINA CORP | 7 | Q3 2017 | 57.2% |
| SPDR S&P 500 ETF TR | 5 | Q3 2017 | 68.1% |
| KULICKE & SOFFA INDS INC | 5 | Q4 2016 | 21.0% |
| 58 COM INC | 4 | Q3 2016 | 32.0% |
| ELLIE MAE INC | 4 | Q3 2016 | 16.2% |
| ALIBABA GROUP HLDG LTD | 4 | Q3 2017 | 4.0% |
| NETEASE INC | 3 | Q3 2017 | 14.0% |
| NXP SEMICONDUCTORS N V | 3 | Q3 2016 | 3.0% |
| IKANG HEALTHCARE GROUP INC | 3 | Q2 2016 | 1.4% |
| ALPHABET INC | 2 | Q1 2017 | 35.0% |
View DYMON ASIA CAPITAL LTD's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2017-11-13 |
| 13F-HR | 2017-08-11 |
| 13F-HR | 2017-05-12 |
| 13F-HR | 2017-02-13 |
| 13F-HR | 2016-11-10 |
| 13F-HR | 2016-08-12 |
| 13F-HR | 2016-05-13 |
| 13F-HR | 2016-04-19 |
View DYMON ASIA CAPITAL LTD's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.